|By PR Newswire||
|March 20, 2014 08:08 AM EDT||
LONDON, March 20, 2014 /PRNewswire/ --
The US markets saw a negative sentiment on Wednesday, March 19, 2014, with the NASDAQ Composite closing at 4,307.60, down 0.59%, the Dow Jones Industrial Average ending the session at 16,222.17, down 0.70% and the S&P 500 edging 0.61% lower to finish the trading session at 1,860.77. The losses were broad based as all the ten sectors ended the session in negative. A number of stocks saw large movements, including First Solar Inc. (NASDAQ: FSLR), Oncothyreon Inc. (NASDAQ: ONTY), Unilife Corp. (NASDAQ: UNIS), and Synthetic Biologics Inc. (AMEX: SYN). Free technical research on FSLR, ONTY, UNIS, and SYN can be downloaded upon signing up at:
Shares in First Solar Inc. edged 20.57% higher, finishing Wednesday's session at $69.40, hitting a new 52-week high of $70.99. The stock fluctuated between $56.96 and $70.99 during the session with a trading volume of 30.82 million shares as compared to a three months average volume of 4.00 million shares. Shares in First Solar Inc. have gained 28.45% in the previous three trading sessions and 22.27% in the last three months. The company's shares are traded at a PE ratio of 16.65 and have gone up 27.01% on YTD basis. The S&P 500 Information Technology Sector Index mapped a loss of 0.52% during the trading session and charted up 1.14% in the last one month. Furthermore, the stock is trading at the RSI of 57.82 and above its 50-day and 200-day moving averages of $53.03 and $49.60, respectively. Sign up today to read free research on FSLR at:
Oncothyreon Inc.'s stock closed Wednesday's session at $3.60, which is 6.19% higher than the previous day's closing price of $3.39. A total of 1.94 million shares were traded as compared to a three months average volume of 0.94 million shares. The stock oscillated between $3.19 and $3.62 during the trading session. Oncothyreon Inc.'s shares have surged 24.14% in the last one month, 103.39% in the previous three months and 104.55% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 0.37% during the trading session and charted up 8.42% in the previous three months. Moreover, the stock is trading at the RSI of 56.49 and above its 50-day and 200-day moving averages of $2.69 and $2.03, respectively. Sign up today to read free research on ONTY at:
On Wednesday, shares in Unilife Corp. ended the session at $5.74, up 12.55%, hitting a new 52-week high of $5.80. A total of 5.36 million shares were traded as compared to a three months average volume of 1.13 million shares. During the session, the stock traded between $5.05 and $5.80. Unilife Corp.'s shares have advanced 36.67% in the last one month, 38.65% in the previous three months and 30.45% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 0.37% during the trading session and charted up 1.70% in the last one month. Further, the stock is trading at the RSI of 66.37 and above its 50-day and 200-day moving averages of $4.47 and $3.66, respectively. Sign up today to read free research on UNIS at:
Synthetic Biologics Inc.'s stock finished Wednesday's session at $3.45, recording a 9.52% gain, after hitting a new 52-week high of $3.64. A total of 5.35 million shares were traded which is above the three months average volume of 1.15 million shares. The stock vacillated between $3.25 and $3.64 during the session. Synthetic Biologics Inc.'s shares have rallied 26.84% in the last one month, 210.81% in the previous three months and 125.49% on YTD basis. The S&P 500 Health Care Sector Index declined 0.37% during the trading session, while the same has gained 1.72% in the previous three trading sessions. Additionally, the stock is trading at the RSI of 70.13 and above its 50-day and 200-day moving averages of $2.28 and $1.72, respectively. Sign up today to read free research on SYN at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Oct. 26, 2016 01:00 PM EDT Reads: 4,994
Oct. 26, 2016 12:45 PM EDT Reads: 8,543
Oct. 26, 2016 12:45 PM EDT Reads: 1,156
Oct. 26, 2016 12:45 PM EDT Reads: 555
Oct. 26, 2016 12:45 PM EDT Reads: 370
Oct. 26, 2016 12:30 PM EDT Reads: 922
Oct. 26, 2016 12:30 PM EDT Reads: 3,949
Oct. 26, 2016 12:15 PM EDT Reads: 2,226
Oct. 26, 2016 12:15 PM EDT Reads: 1,586
Oct. 26, 2016 12:00 PM EDT Reads: 4,619
Oct. 26, 2016 12:00 PM EDT Reads: 3,547
Oct. 26, 2016 12:00 PM EDT Reads: 2,885
I'm a lonely sensor. I spend all day telling the world how I'm feeling, but none of the other sensors seem to care. I want to be connected. I want to build relationships with other sensors to be more useful for my human. I want my human to understand that when my friends next door are too hot for a while, I'll soon be flaming. And when all my friends go outside without me, I may be left behind. Don't just log my data; use the relationship graph. In his session at @ThingsExpo, Ryan Boyd, Engi...
Oct. 26, 2016 11:45 AM EDT Reads: 1,880
There is growing need for data-driven applications and the need for digital platforms to build these apps. In his session at 19th Cloud Expo, Muddu Sudhakar, VP and GM of Security & IoT at Splunk, will cover different PaaS solutions and Big Data platforms that are available to build applications. In addition, AI and machine learning are creating new requirements that developers need in the building of next-gen apps. The next-generation digital platforms have some of the past platform needs a...
Oct. 26, 2016 11:45 AM EDT Reads: 2,339
Join Impiger for their featured webinar: ‘Cloud Computing: A Roadmap to Modern Software Delivery’ on November 10, 2016, at 12:00 pm CST. Very few companies have not experienced some impact to their IT delivery due to the evolution of cloud computing. This webinar is not about deciding whether you should entertain moving some or all of your IT to the cloud, but rather, a detailed look under the hood to help IT professionals understand how cloud adoption has evolved and what trends will impact th...
Oct. 26, 2016 11:45 AM EDT Reads: 512